Evidence map›Paper›PMID 35547928›Full record

ArticleRSC advances2018

Theoretical and experimental investigation of anticancer activities of an acyclic and symmetrical compartmental Schiff base ligand and its Co(ii), Cu(ii) and Zn(ii) complexes.

Lotfali Saghatforoush, Keyvan Moeini, Seyed Abolfazl Hosseini-Yazdi, Zahra Mardani, Alireza Hajabbas-Farshchi, Heather T Jameson, Shane G Telfer, J Derek Woollins

Abstract read
In one paragraph

Article in RSC advances, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 3 papers.

0numbers the graph read from it
0cells of the map it votes in
3citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

3 citing papers in PubMed.

  1. Review
  2. Review
  3. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Lotfali SaghatforoushDepartment of Chemistry, Payame Noor University 19395-4697 Tehran I. R. Iran saghatforoush@gmail.com l_saghatf@pnu.ac.ir +98 4436332556 +98 4436332344.ORCID https://orcid.org/0000-0001-6781-455X
Keyvan MoeiniDepartment of Chemistry, Payame Noor University 19395-4697 Tehran I. R. Iran saghatforoush@gmail.com l_saghatf@pnu.ac.ir +98 4436332556 +98 4436332344.ORCID https://orcid.org/0000-0003-4051-886X
Seyed Abolfazl Hosseini-YazdiDepartment of Inorganic Chemistry, Faculty of Chemistry, University of Tabriz Tabriz 51666-14766 I. R. Iran.
Zahra MardaniInorganic Chemistry Department, Faculty of Chemistry, Urmia University 57561-51818 Urmia I. R. Iran.ORCID https://orcid.org/0000-0002-3749-5399
Alireza Hajabbas-FarshchiDepartment of Immunology, Faculty of Microbiology, Urmia University 57561-51818 Urmia I. R. Iran.ORCID https://orcid.org/0000-0003-1571-0446
Heather T JamesonMacDiarmid Institute for Advanced Materials and Nanotechnology, Massey University Palmerston North New Zealand.
Shane G TelferMacDiarmid Institute for Advanced Materials and Nanotechnology, Massey University Palmerston North New Zealand.ORCID https://orcid.org/0000-0003-1596-6652
J Derek WoollinsEaStCHEM School of Chemistry, University of St Andrews St Andrews, Fife UK KY16 9ST.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

A compartmental Schiff base ligand, 2,2'-((((((2-hydroxypropane-1,3-diyl)bis(oxy))bis(2,1-phenylene))bis(methylene))bis(azanylylidene))bis(methanylylidene))bis(4-bromophenol) (H

Identifiers

PMID35547928
PMCPMC9088086

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.